Wachovia upgrades MedCath (Nasdaq: MDTH) to Outperform and has a $29-$30 valuation range.

The firm said MedCath is set ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE